Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05817331

Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire

Sponsor: Otsuka Australia Pharmaceutical Pty Ltd

View on ClinicalTrials.gov

Summary

The primary goal of this study is to use qualitative interviews to elicit and confirm concepts related to treatment preferences and understandability of the pTPMQ, cTPMQ, and mTPMQ. The information gathered will be used to support the appropriateness of the questionnaires as a patient-reported, caregiver-reported and clinician-reported outcome measure (PROM) in the population of interest.

Official title: Qualitative Interviews to Refine and Assess the Importance of Constructs, and Ensure the Readability of Patient, Carer, and Clinician Versions of the Treatment Preference in Myelodysplasia Questionnaire (TPMQ): pTPMQ, cTPMQ, and mTPMQ, Respectively

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

16

Start Date

2022-06-28

Completion Date

2023-03-10

Last Updated

2026-10-29

Healthy Volunteers

No

Interventions

OTHER

Carer Treatment Preference Myelodysplasia Questionnaire

Caregiver-reported outcome measure in MDS

OTHER

Clinician Treatment Preference Myelodysplasia Questionnaire

Clinician-reported outcome measure in MDS

OTHER

Patient Treatment Preference Myelodysplasia Questionnaire

Patient-reported outcome measure (PROM) in MDS

Locations (1)

Calvary Mater Newcastle

Newcastle, New South Wales, Australia